Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Infect Dis ; 199(10): 1449-56, 2009 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-19351262

RESUMO

BACKGROUND: The aim of the present study was to estimate the prevalence of Kaposi sarcoma-associated herpesvirus (KSHV) in the female general population, to define geographic variation in and heterosexual transmission of the virus. METHODS: The study included 10,963 women from 9 countries for whom information on sociodemographic characteristics and reproductive, sexual, and smoking behaviors were available. Antibodies against KSHV that encoded lytic antigen K8.1 and latent antigen ORF73 were determined. RESULTS: The range of prevalence of KSHV (defined as detection of any antigen) was 3.81%-46.02%, with significant geographic variation noted. In Nigeria, the prevalence was 46.02%; in Colombia, 13.32%; in Costa Rica, 9.81%; in Argentina, 6.40%; in Ho Chi Minh City, Vietnam, 15.50%; in Hanoi, Vietnam, 11.26%; in Songkla, Thailand, 10%; in Lampang, Thailand, 8.63%; in Korea, 4.93%; and in Spain, 3.65%. The prevalence of KSHV slightly increased with increasing age among subjects in geographic areas where the prevalence of KSHV was high, such as Nigeria and Colombia, and it significantly decreased with increases in the educational level attained by subjects in those areas. KSHV was not statistically associated with age at first sexual intercourse, number of sex partners, number of children, patterns of oral contraceptive use, presence of cervical human papillomavirus DNA, or smoking status. CONCLUSIONS: The study provides comparable estimates of KSHV prevalence in diverse cultural settings across 4 continents and provides evidence that sexual transmission of KSHV is not a major source of infection in the general population.


Assuntos
Glicoproteínas/genética , Sarcoma de Kaposi/genética , Proteínas Virais/genética , Adulto , Antígenos Virais/genética , Colômbia/epidemiologia , Comparação Transcultural , Feminino , Glicoproteínas/isolamento & purificação , Infecções por Herpesviridae/epidemiologia , Infecções por Herpesviridae/genética , Infecções por Herpesviridae/transmissão , Herpesvirus Humano 8 , Humanos , Pessoa de Meia-Idade , Nigéria/epidemiologia , Razão de Chances , Prevalência , Fatores de Risco , Sarcoma de Kaposi/epidemiologia , Comportamento Sexual , Tailândia/epidemiologia , Proteínas Virais/isolamento & purificação
2.
Sex Transm Dis ; 34(8): 563-9, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17417132

RESUMO

OBJECTIVES: Better information on the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection is needed in many world areas. STUDY DESIGN: Cross-sectional study of population-based samples of nonpregnant women aged 15 to 44 years in Nigeria, Colombia, Argentina, Vietnam (2 areas), China, Thailand (2 areas), Korea, and Spain. 5,328 consenting women aged 15 to 44 years participated. Exfoliated cervical cells were collected and testing for CT and NG and human papillomavirus (HPV) was done using PCR-based assays. RESULTS: Age-standardized CT prevalence ranged between 0.2% (95% confidence interval, CI: 0.0-0.7%) in Spain and 5.6% (95% CI: 3.4-7.8%) in Nigeria. NG ranged between 0% (with broad CIs) in several areas and 2.6% (95% CI: 1.0-4.2%) in Nigeria. Prevalence of CT in all areas combined was greater in women aged 15 to 24 (4.5; 95% CI: 3.4-5.8%) than 25 to 44 (2.6; 95% CI: 2.1-3.1%), whereas NG prevalence was similar in the 2 age groups (0.3%). The only significant risk factors were NG infection (for CT), CT infection (for NG) and infection with high-risk HPV types (for both). CONCLUSIONS: The prevalence of CT and, most notably, NG was relatively low in a variety of countries. Our findings, however, do not apply to subsets of high-risk women who are likely to be underrepresented in our population-based samples.


Assuntos
Infecções por Chlamydia/epidemiologia , Chlamydia trachomatis , Gonorreia/epidemiologia , Doenças do Colo do Útero/epidemiologia , Adolescente , Adulto , Ásia/epidemiologia , Infecções por Chlamydia/etiologia , Infecções por Chlamydia/prevenção & controle , Colômbia/epidemiologia , Estudos Transversais , Feminino , Gonorreia/etiologia , Gonorreia/prevenção & controle , Humanos , Neisseria gonorrhoeae , Nigéria/epidemiologia , Prevalência , Fatores de Risco , Espanha/epidemiologia , Doenças do Colo do Útero/etiologia , Doenças do Colo do Útero/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA